The Curative Service Division (CSD), DoHS has released a new guideline on Clinical Management of Mpox (Monkeypox), aims to provide a scientific guidance to healthcare providers. This interim guidance was developed based on the learnings of endemic countries and recent scientific evidences.
This document will provides a summary of the diseases etiology, preventive measures, infection, prevention and control and clinical case management. As ongoing outbreak of mpox is declared as the Public Health Emergency of International Concern (PHEIC) on 23rd July 2022 by WHO, this guideline will facilitate policy makers and healthcare providers to prevent, treat and manage Mpox in local context of Nepal.
Table of contents
- Natural History and Disease Severity
- Clinical features
- Laboratory diagnosis
- Case definitions for mpox outbreak in non-endemic countries
- Infection Prevention and Control
- Antivirals and Vaccines
- Risk Management
- Preventive Measure
- Living Guidance for Integrating Gender, Equity and Human Rights (GER)
- WHO RECOMMENDS NEW NAME FOR MONKEYPOX DISEASE
- PUBLIC HEALTH ADVICE FOR GATHERINGS DURING THE CURRENT MONKEYPOX OUTBREAK
- WORLD HEALTH ORGANIZATION (WHO) DECLARES MONKEYPOX A PUBLIC HEALTH EMERGENCY
- MONKEYPOX ENDEMIC NEWS: WHAT IS MONKEYPOX?, SYMPTOMS AND PREVENTIVE MEASURES
- ONE HEALTH JOINT PLAN OF ACTION LAUNCHED TO ADDRESS HEALTH THREATS TO HUMANS, ANIMALS, PLANTS AND ENVIRONMENT
[…] Interim Guidance on Clinical Management of Mpox (Monkeypox) 2079 […]
Comments are closed.